Hydrocortisone Ennogen Ip (Hydrocortisone)

Hydrocortisone Ennogen Ip is commonly employed for a range of mild to moderate skin conditions where inflammation or itching is present.

• Relief of mild eczema or atopic dermatitis.
• Treatment of contact dermatitis caused by irritants or allergens.
• Management of insect bite reactions and localized rash.
• Reduction of redness and swelling from minor burns or abrasions.
• Soothing of allergic skin reactions such as hives or urticaria.

• Hydrocortisone Ennogen Ip works by penetrating the epidermis and binding to intracellular glucocorticoid receptors. This receptor complex translocates to the nucleus, where it interacts with glucocorticoid response elements on DNA, altering transcription of multiple genes. The resulting changes suppress the synthesis of pro‑inflammatory cytokines, prostaglandins, and leukotrienes, while enhancing the production of anti‑inflammatory proteins, thereby reducing redness, swelling, and immune cell activity in the skin.

Topical application of Hydrocortisone Ennogen Ip may be associated with local skin reactions, most of which are mild and reversible.

Common

• Transient burning, stinging, or itching at the application site.
• Mild skin dryness or peeling.
• Slight erythema or redness.
• Temporary worsening of the rash before improvement.

Serious

• Skin atrophy or thinning with prolonged use.
• Development of telangiectasia (visible small blood vessels).
• Allergic contact dermatitis to the formulation.
• Suppression of the hypothalamic‑pituitary‑adrenal (HPA) axis with extensive application.

Before using Hydrocortisone Ennogen Ip, consider the following precautions to minimize risks and ensure appropriate therapy.

• Avoid application on broken, infected, or ulcerated skin unless directed by a healthcare professional.
• Limit use to the prescribed area and duration; prolonged or extensive application can increase systemic absorption.
• Do not use on the face, groin, or underarms for extended periods unless specifically advised.
• Consult a physician before use in children, pregnant or breastfeeding individuals, as safety data are limited.
• Discontinue if signs of an allergic reaction, such as rash, swelling, or severe itching, develop.
• Store the product at room temperature, protected from moisture and direct sunlight.

Hydrocortisone Ennogen Ip can interact with other topical agents or systemic medications that affect corticosteroid activity or skin integrity.

Avoid

• Concurrent use with other potent topical corticosteroids on the same area, which may increase the risk of skin atrophy.
• Application together with occlusive dressings that enhance drug absorption unless instructed.
• Use with topical antibiotics or antifungals that are known irritants, unless combined in a single formulation.

Use with caution

• Systemic corticosteroids, as combined effects may suppress the HPA axis.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied to the same site, which could increase local irritation.
• Antihistamines or immunosuppressants, where monitoring of skin healing may be required.